Startups Weekly: No sign of pause

This week's startup news includes neobank Chime's IPO after a near-death experience in 2016, and genetics testing startup Nucleus Genomics facing criticism for its embryo selection product. In venture funding, Multiverse Computing raised €189M for its LLM compression technology, Glean secured a $150M Series F at a $7.2B valuation, and Fervo Energy obtained $206M for geothermal plant development, highlighting continued investment in AI and energy sectors. Additionally, the U.S. Navy is actively seeking partnerships with startups to enhance innovation adoption.

Analysis

The startup ecosystem exhibits sustained momentum, with neobank Chime executing a significant IPO despite a near-insolvency event in 2016, demonstrating market appetite for fintech ventures with resilient narratives. M&A activity is also present, exemplified by Automattic's acquisition of Clay, a personal CRM startup that had previously raised over $9 million. Venture capital deployment remains robust across multiple high-growth sectors, underscored by a strongly positive sentiment score of 0.75. Notably, AI-focused companies attracted substantial funding: Multiverse Computing raised €189 million (approximately $215 million) in a Series B for its LLM compression technology, enterprise AI firm Glean secured a $150 million Series F, elevating its valuation to $7.2 billion from $4.6 billion in September 2024, AI sales startup Landbase closed a $30 million Series A, and AI legal tech Definely raised a $30 million Series B. The energy sector also saw major investments, with Fervo Energy obtaining $206 million for geothermal power development and German fusion startup Proxima Fusion securing a €130 million Series A. Other significant rounds include an $80 million Series D for hotel guest management platform Canary, $80 million raised by delivery robot startup Coco Robotics between 2021 and 2024, and a €30 million investment in fintech Tebi, led by Alphabet's CapitalG. Collab Capital also closed a $75 million Fund II. However, the innovation landscape is not without challenges, as evidenced by the criticism faced by Nucleus Genomics for its embryo selection product, highlighting emerging ethical considerations in biotechnology. The U.S. Navy's expressed interest in fostering partnerships with startups further signals opportunities for enterprise-focused innovation.

Key Decisions for Investors

• Investors should monitor the continued strong capital inflow into private AI and energy technology companies, such as Multiverse Computing, Glean, Fervo Energy, and Proxima Fusion, as these indicate sectors with high growth potential and future public market candidates.
• The IPO of Chime, following a significant turnaround, suggests that late-stage private markets and IPOs can offer substantial returns, but require careful due diligence regarding company fundamentals and resilience.
• Alphabet's (GOOGL) strategic investment in fintech through CapitalG's lead in Tebi's funding round reinforces its commitment to the sector, potentially offering ancillary benefits to GOOGL's broader ecosystem and long-term value.
• The ethical debate surrounding Nucleus Genomics' new product underscores the increasing importance of incorporating ESG factors and ethical reviews into due diligence processes, particularly for investments in cutting-edge biotech and healthcare startups.